Congratulations to these 2020 NNECOS Research Grant Recipients Cycle 2
Diego Adrianzen, M.D., Assistant Professor of Medicine and
Neil Zakai, M.D., M.Sc., Associate Professor of Medicine
Hematology/Oncology Division, Larger College of Medicine at the University of Vermont
Identifying Factors Associated With Cardiovascular Disease In Myelodysplastic Syndromes: An Analysis Of The Seer-Medicare Database
The primary objective of this study is to determine the sociodemographic and patient-specific clinical risk factors associated with increased risk of CVD and cardiovascular mortality in patients with MDS. The secondary objective is to determine the impact of MDS-specific therapeutic interventions (hypomethylating agents, iron chelation and growth factors) on hazard for new CVD or cardiovascular mortality in MDS patients.